Lucid Diagnostics to Release Earnings on Tuesday - MarketBeat

LUCD Stock  USD 0.84  0.01  1.18%   
About 61% of Lucid Diagnostics' investor base is looking to short. The analysis of overall sentiment of trading Lucid Diagnostics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Lucid Diagnostics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lucid Diagnostics stock news signals to limit their universe of possible portfolio assets.
  
Lucid Diagnostics to Release Earnings on Tuesday MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Lucid Diagnostics Fundamental Analysis

We analyze Lucid Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lucid Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lucid Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Lucid Diagnostics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Lucid Diagnostics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lucid Diagnostics stock to make a market-neutral strategy. Peer analysis of Lucid Diagnostics could also be used in its relative valuation, which is a method of valuing Lucid Diagnostics by comparing valuation metrics with similar companies.

Peers

Lucid Diagnostics Related Equities

XAIRBeyond Air   13.51   
0%
100.0%
KIDSOrthopediatrics Corp   2.37   
0%
17.0%
FNAParagon 28   2.06   
0%
15.0%
CVRXCVRx   1.85   
0%
13.0%
IRMDIradimed   1.39   
0%
10.0%
OFIXOrthofix Medical   1.12   
0%
8.0%
LIVNLivaNova PLC   0.67   
0%
4.0%
SRDXSurModics   0.66   
0%
4.0%
CLPTClearpoint Neuro   0.53   
0%
3.0%
NPCENeuropace   0.50   
0%
3.0%
ELMDElectromed   0.38   
0%
2.0%
ITGRInteger Holdings   0.31   
0%
2.0%
NARIInari Medical   0.19   
0%
1.0%
LUNGPulmonx Corp   2.19   
16.0%
0%

Complementary Tools for Lucid Stock analysis

When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital